|
NCK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29709576413006E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.98840000001466E-06 |
| Normal-vs-Stage2 |
1.196330E-04 |
| Normal-vs-Stage3 |
5.54360000000198E-05 |
| Normal-vs-Stage4 |
1.004270E-02 |
| Stage1-vs-Stage2 |
1.028160E-02 |
| Stage1-vs-Stage3 |
2.892500E-02 |
| Stage1-vs-Stage4 |
2.177800E-01 |
| Stage2-vs-Stage3 |
6.116200E-01 |
| Stage2-vs-Stage4 |
5.605400E-01 |
| Stage3-vs-Stage4 |
8.522400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.18879955563523E-10 |
| Normal-vs-AfricanAmerican |
7.12730000018702E-07 |
| Normal-vs-Asian |
8.798100E-02 |
| Caucasian-vs-AfricanAmerican |
5.779400E-01 |
| Caucasian-vs-Asian |
4.275800E-01 |
| AfricanAmerican-vs-Asian |
5.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04520003763042E-09 |
| Normal-vs-Female |
2.26829999228073E-09 |
| Male-vs-Female |
9.815800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.800100E-03 |
| Normal-vs-Extreme_Weight |
2.37000000002929E-06 |
| Normal-vs-Obese |
8.62769999998569E-07 |
| Normal-vs-Extreme_Obese |
9.140500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.142400E-01 |
| Normal_Weight-vs-Obese |
5.073800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.980800E-01 |
| Extreme_Weight-vs-Obese |
8.681600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.786200E-01 |
| Obese-vs-Extreme_Obese |
7.923600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.774000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.39069883281695E-11 |
| Normal-vs-Age(61-80Yrs) |
9.93350000033644E-07 |
| Normal-vs-Age(81-100Yrs) |
1.502260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.921800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.067700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.532020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.690100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.916200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.705200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.40840000667697E-09 |
| Normal-VS-Type2 PRCC |
1.66860999999408E-05 |
| Normal-VS-KIRP CIMP |
3.824800E-04 |
| Normal-VS-Unclassified PRCC |
3.53060000002348E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.377200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.396250E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.103500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.675800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.607180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.882600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.417100E-04 |
| Normal-vs-N1 |
2.635000E-04 |
| Normal-vs-N2 |
7.029800E-02 |
| N0-vs-N1 |
4.037700E-02 |
| N0-vs-N2 |
3.643000E-01 |
| N1-vs-N2 |
7.507600E-01 |
|
|
